Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Patients with coronary artery disease or heart failure have been shown to be insulin resistant.Whether in these patients heart muscle participates in the insulin resistance, and whether reduced blood flow is a mechanism for such resistance is not known.We measured heart and skeletal muscle blood flow and glucose uptake during euglycemic hyperinsulinemia (insulin clamp) in 15 male patients with angiographically proven coronary artery disease and chronic regional wall motion abnormalities.Six age-and weightmatched healthy subjects served as controls.Regional glucose uptake was measured by positron emission tomography using [ 18 F]2-fluoro-2-deoxy-D -glucose (FDG), blood flow was measured by the H 2 15 O method.Myocardial glucose utilization was measured in regions with normal perfusion and wall motion as assessed by radionuclide ventriculography.Whole-body glucose uptake was 37 Ϯ 4 mol и min Ϫ 1 и kg Ϫ 1 in controls and 14 Ϯ 2 mol и min Ϫ 1 и kg Ϫ 1 in patients ( P ϭ 0.001).Myocardial blood flow (1.09 Ϯ 0.06 vs. 0.97 Ϯ 0.04 ml и min Ϫ 1 и g Ϫ 1 , controls vs. patients) and skeletal muscle (arm) blood flow (0.046 Ϯ 0.012 vs. 0.043 Ϯ 0.006 ml и min Ϫ 1 и g Ϫ 1 ) were similar in the two groups ( P ϭ NS for both).In contrast, in patients both myocardial (0.38 Ϯ 0.03 vs. 0.70 Ϯ 0.03 mol и min Ϫ 1 и g Ϫ 1 , P ϭ 0.0005) and muscle glucose uptake (0.026 Ϯ 0.004 vs. 0.056 Ϯ 0.006 mol и min Ϫ 1 и g Ϫ 1 , P ϭ 0.005) were markedly reduced in comparison with controls.In the whole dataset, a direct relationship existed between insulin-stimulated glucose uptake in heart and skeletal muscle.Patients with a history of myocardial infarction and a low ejection fraction are insulin resistant.This insulin resistance affects both the myocardium and skeletal muscle and is independent of blood flow.( J. Clin.Invest.1996.98:2094-2099.)Key words: insulin resistance • coronary heart disease • skeletal muscle • myocardial muscle 15 O).Euglycemic hyperinsulinemia measures whole-body insulin resistance and enhances the FDG signal during PET (14).The model chosen was the noninfarcted myocardium of patients who have suffered from an acute myocardial infarction. Methods Patients.The patient population consisted of 15 normotensive, nondiabetic men (aged 54 Ϯ 2 years, range 34-62) with coronary artery disease.All patients had suffered a previous myocardial infarction at least 6 mo before the study.All patients had at least one ventricular
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 1×
“Norepinephrine can increase free fatty acid (FFA) levels (52), and FFA in turn can decrease glucose utilization both in heart (5) and skeletal muscle (53) by substrate competition (54).”
BackgroundDeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM
Mitrakou, A., Kelley, D., Veneman, T., Jenssen, T., Pangburn, T., Reilly, J., & Gerich, J. (1990) · Diabetes · doi:10.2337/diab.39.11.1381 · Cited by 317
Kelley, D. E., & Mandarino, L. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114935 · Cited by 210 · cited 1×
“Thus, the arm skeletal muscle blood flow rates measured by PET in the present study are in the range of those measured in the forearm of healthy subjects during a euglycemic clamp with the use of an indicator dilution method (30) or by venous occlusion plethysmography (31).”
MethodHormonal effects of norepinephrine on acute glucose disposal in humans: A minimal model analysis
Marangou, A. G., Alford, F. P., Ward, G., Liskaser, F., Aitken, P. M., Weber, K. M., Boston, R. C., & Best, J. D. (1988) · Metabolism · doi:10.1016/0026-0495(88)90124-2 · Cited by 83
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
Ferrannini, E., Mark, M., & Mayoux, E. (2016) · Diabetes Care · doi:10.2337/dc16-0330 · Cited by 975
“However, in patients with T2D (27,46) as well as in patients without diabetes with coronary artery disease (47) or stress-induced ischemia (48), whole-body and myocardial insulin-mediated glucose utilization are impaired (i.”
BackgroundSelf-citationDeFronzo, R. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1684-1 · Cited by 879
Metabolic remodelling in heart failure
Bertero, E., & Maack, C. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0044-6 · Cited by 706
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
How to measure insulin sensitivity
Ferrannini, E., & Mari, A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00001 · Cited by 512
Self-citationAcylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
Metabolic Coordination of Physiological and Pathological Cardiac Remodeling
Gibb, A. A., & Hill, B. G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312017 · Cited by 387
MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism
Lu, H., Buchan, R. J., & Cook, S. A. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq010 · Cited by 334
Osorio, J. C., Stanley, W. C., Linke, A., Castellari, M., Diep, Q. N., Panchal, A. R., Hintze, T. H., Lopaschuk, G. D., & Recchia, F. A. (2002) · Circulation · doi:10.1161/01.cir.0000023531.22727.c1 · Cited by 332
DeFronzo, R. A., & Abdul-Ghani, M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.013 · Cited by 317
Recchia, F. A., McConnell, P. I., Bernstein, R. D., Vogel, T. R., Xu, X., & Hintze, T. H. (1998) · Circulation Research · doi:10.1161/01.res.83.10.969 · Cited by 302
“strated that NO potentiates insulin-mediated uptake of glucose in skeletal muscle(58) and, indeed, patients with heart failure present moderate insulin resistance.(59)”
BackgroundNi, Y. G., Wang, N., Cao, D. J., Sachan, N., Morris, D. J., Gerard, R. D., Kuro-o, M., Rothermel, B. A., & Hill, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610290104 · Cited by 279
Pathophysiology of prediabetes
Ferrannini, E., Gastaldelli, A., & Iozzo, P. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.005 · Cited by 177
Self-citationYue, T.-L., Bao, W., Gu, J.-L., Cui, J., Tao, L., Ma, X.-L., Ohlstein, E. H., & Jucker, B. M. (2005) · Diabetes · doi:10.2337/diabetes.54.2.554 · Cited by 170
Clerk, L. H., Rattigan, S., & Clark, M. G. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1138 · Cited by 159
“Skeletal muscle accounts for 80% of the insulinmediated glucose uptake (IMGU) after a meal (1) and becomes resistant to insulin in type 2 diabetes (2), hypertension (3), obesity (4), and severe forms of stress (5).”
BackgroundDiabetes Mellitus and Heart Failure
Jagasia, D., & McNulty, P. H. (2003) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00901.x · Cited by 38
Metadata
- Authors
- Paternostro, G., Camici, P. G., Lammerstma, A. A., Marinho, N., Baliga, R. R., Kooner, J. S., Radda, G. K., & Ferrannini, E.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-11-01
- Volume
- 98
- Issue
- 9
- Pages
- 2094-2099
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2036515253
- Cited by
- 150
- References
- 7
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.